The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index; none of the 21 sources its claims cite is checked for support yet.
Differential Recognition of the Type I and II H Antigen Acceptors by the Human ABO(H) Blood Group A and B Glycosyltransferases
Open accessAbstract
The human ABO(H) blood group A and B antigens are generated by the homologous glycosyltransferases A (GTA) and B (GTB), which add the monosaccharides GalNAc and Gal, respectively, to the cell-surface H antigens. In the first comprehensive structural study of the recognition by a glycosyltransferase of a panel of substrates corresponding to acceptor fragments, 14 high resolution crystal structures of GTA and GTB have been determined in the presence of oligosaccharides corresponding to different segments of the type I (alpha-l-Fucp-(1-->2)-beta-D-Galp-(1-->3)-beta-D-GlcNAcp-OR, where R is a glycoprotein or glycolipid in natural acceptors) and type II (alpha-l-Fucp-(1-->2)-beta-D-Galp-(1-->4)-beta-d-GlcNAcp-OR) H antigen trisaccharides. GTA and GTB differ in only four "critical" amino acid residues (Arg/Gly-176, Gly/Ser-235, Leu/Met-266, and Gly/Ala-268). As these enzymes both utilize the H antigen acceptors, the four critical residues had been thought to be involved strictly in donor recognition; however, we now report that acceptor binding and subsequent transfer are significantly influenced by two of these residues: Gly/Ser-235 and Leu/Met-266. Furthermore, these structures show that acceptor recognition is dominated by the central Gal residue despite the fact that the L-Fuc residue is required for efficient catalysis and give direct insight into the design of model inhibitors for GTA and GTB.
Overview
CoChat Summary
TL;DR
The human ABO(H) blood group A and B glycosyltransferases GTA and GTB were crystallized with 14 acceptor-fragment complexes, showing that two “critical” residues previously tied to donor recognition—Gly/Ser-235 and Leu/Met-266—also differentially affect acceptor binding. Acceptor recognition is dominated by the central Gal residue, while the L-Fuc residue remains required for efficient catalysis.
Key findings
- Fourteen high-resolution crystal structures of GTA and GTB were determined with Gal, Gal-gr, Lac, LacNAc, βMeLac, HI-octyl, and HII-gr; acceptor electron density was seen in every complex except GTA·Lac and GTA·βMeLac. Diffraction data reached 1.85–1.49 Å, with Rwork 0.197–0.211 and Rfree 0.220–0.236.
- The critical residues Gly/Ser-235 and Leu/Met-266 significantly influence acceptor binding: GTB generally showed higher acceptor occupancy/order than GTA. Met-266 in GTB positions a water molecule bridging Gal and Glu-303, whereas Leu-266 in GTA displaces it; Ser-235 in GTB can hydrogen-bond Glc/GlcNAc residues, while Gly-235 in GTA cannot.
- Relative transfer rates versus HA-octyl were HI-octyl 41% (GTA) and 69% (GTB), and HII-gr 79% (GTA) and 90% (GTB). Non-fucosylated acceptors were much lower: Gal-gr 2.0% (GTA) and 0.52% (GTB), Lac-gr 0.48% and 0.21%, and LacNAc-gr 0.30% and 0.16%.
- Kinetic constants at 5 mM donor: HA-octyl Km 87 ± 6 µM (GTA) and 22 ± 3 µM (GTB); HI-octyl Km 1300 ± 140 µM (GTA) and 1600 ± 180 µM (GTB); HII-gr Km 490 ± 50 µM (GTA) and 184 ± 23 µM (GTB). The central Gal residue forms most enzyme contacts, and the L-Fuc residue is required for efficient catalysis.
Methods
- Crystallography: GTA and GTB were crystallized with seven acceptor fragments, yielding 14 possible complexes. Structures were solved by molecular replacement using wild-type GTA or GTB (PDB 1LZ0 and 1LZ7) and refined with CNS.
- Enzyme kinetics: soluble catalytic domains of GTA and GTB (amino acids 63–354) were expressed in *Escherichia coli* and purified. Radiochemical assays used 1 mM acceptor, 1 mM UDP-Gal or UDP-GalNAc, 50 mM MOPS pH 7.0, BSA, and MnCl2 at 37 °C; kinetics for HI-octyl and HII-gr varied acceptor with donor fixed at 5 mM, and kcat/Km were obtained by nonlinear regression to the Michaelis-Menten equation.
- Preparative reactions with Lac-gr, LacNAc-gr, and GTA/GTB were used to confirm product formation, with products characterized by 1H NMR as containing α1-3-linked Gal or GalNAc.
Limitations
- The paper states that caution must be exercised in drawing direct correlations between resting crystal structures and kinetic data.
- The paper states that detailed two-substrate kinetics with HI-octyl and HII-gr were not possible because insufficient material was available, and complete kinetic parameters for substrates lacking L-Fuc could not be determined.
- The paper states there are no comprehensive studies on the relative distribution of type I and II H antigens between ABO(H) A and B blood groups, so in vivo relevance remains speculative. Evident from the text: several structures had disorder in the loop around residues 175–195, the 10 C-terminal residues, and some acceptor residues, and the alkyl tails on the type I and II H antigen trisaccharides were not observed in ordered conformations.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
0 Valid · 0 Not valid · 18 Not checked · 77 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“however, we now report that acceptor binding and subsequent transfer are significantly influenced by two of these residues: Gly/Ser-235 and Leu/Met-266.”
§ Differential Recognition of the Type I and II H Antigen Acceptors by the Human ABO(H) Blood Group A and B Glycosyltransferases * > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Furthermore, these structures show that acceptor recognition is dominated by the central Gal residue despite the fact that the L-Fuc residue is required for efficient catalysis”
§ Differential Recognition of the Type I and II H Antigen Acceptors by the Human ABO(H) Blood Group A and B Glycosyltransferases * > Abstract
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Electron density corresponding to the type II H antigen trisaccharide acceptor was observed in both GTA and GTB (Fig. 2e).”
§ Differential Recognition of the Type I and II H Antigen Acceptors by the Human ABO(H) Blood Group A and B Glycosyltransferases * > HII-gr Trisaccharide (␣-L-Fucp-(132)--D-Galp-(134)--D-Glc-
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The Glc residue displays only a single hydrogen bond to the enzyme, between the O-1Ј hydroxyl group and the side chain of the critical residue Ser-235 (Fig. 4a).”
§ Differential Recognition of the Type I and II H Antigen Acceptors by the Human ABO(H) Blood Group A and B Glycosyltransferases * > RESULTS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This bridging water molecule is shifted in GTA, where the smaller side chain of Leu-266 allows it to be displaced from Glu-303 to form interactions with two other water molecules (Figs. 3 and 4c).”
§ Differential Recognition of the Type I and II H Antigen Acceptors by the Human ABO(H) Blood Group A and B Glycosyltransferases * > DISCUSSION
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
62 more claims
Create a free account to see all 95 claims and to verify the 21 references still open.
- It may state two separate claims as one. 20
- Probably not a substantial claim. 11
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“whereas Gly/Ser 235 and Leu/Met 266 significantly impact acceptor recognition (33)”
From ABO(H) blood group A and B glycosyltransferases recognize substrate via specific conformational changes (2008) · cites this paper as [33]
In the citing paper
“while Gly/Ser235 has been shown to affect acceptor binding”
From Conserved residues Arg188 and Asp302 are critical for active site organization and catalysis in human ABO(H) blood group A and B glycosyltransferases† (2018) · cites this paper as Letts et al. 2006
In the citing paper
“Critical residue Arg/Gly176 has also been associated with internal loop stability, with Arg176 imparting greater loop order due to more restricted main chain dihedral angles compared to Gly176 (Patenaude et al. 2002; Lee et al. 2005; Letts et al. 2006; Alfaro et al. 2008; Johal et al. 2012).”
From Conserved residues Arg188 and Asp302 are critical for active site organization and catalysis in human ABO(H) blood group A and B glycosyltransferases† (2018) · cites this paper as Letts et al. 2006
Citations
Cites
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
SETOR: Hardware-lighted three-dimensional solid model representations of macromolecules
Evans, S. V. (1993) · Journal of Molecular Graphics · doi:10.1016/0263-7855(93)87009-t · Cited by 1,279
Self-citationThe finer things in X-ray diffraction data collection
Pflugrath, J. W. (1999) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s090744499900935x · Cited by 1,244
An Evolving Hierarchical Family Classification for Glycosyltransferases
Coutinho, P. M., Deleury, E., Davies, G. J., & Henrissat, B. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00307-3 · Cited by 1,211
Molecular genetic basis of the histo-blood group ABO system
Yamamoto, F.-I., Clausen, H., White, T., Marken, J., & Hakomori, S.-I. (1990) · Nature · doi:10.1038/345229a0 · Cited by 1,181
Clausen, H., & Hakomori, S. (1989) · Vox Sanguinis · doi:10.1111/j.1423-0410.1989.tb03040.x · Cited by 504
Hakomori, S. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00183-x · Cited by 341
The structural basis for specificity in human ABO(H) blood group biosynthesis
Patenaude, S. I., Seto, N. O. L., Borisova, S. N., Szpacenko, A., Marcus, S. L., Palcic, M. M., & Evans, S. V. (2002) · Nature Structural Biology · doi:10.1038/nsb832 · Cited by 273
Self-citationYamamoto, F.-I., McNeill, P. D., & Hakomori, S.-I. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81502-5 · Cited by 226
Somsak, L., Nagy, V., Hadady, Z., Docsa, T., & Gergely, P. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033454919 · Cited by 185
Lowary, T. L., & Hindsgaul, O. (1994) · Carbohydrate Research · doi:10.1016/0008-6215(94)84275-2 · Cited by 91
Marcus, S. L., Polakowski, R., Seto, N. O. L., Leinala, E., Borisova, S., Blancher, A., Roubinet, F., Evans, S. V., & Palcic, M. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212002200 · Cited by 85
Self-citation1,3-beta-Glucan Synthase: A Useful Target for Antifungal Drugs
Liu, J., & Balasubramanian, M. K. (2001) · Current Drug Targets - Infectious Disorders · doi:10.2174/1568005014606107 · Cited by 85
Seto, N. O. L., Compston, C. A., Evans, S. V., Bundle, D. R., Narang, S. A., & Palcic, M. M. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00086.x · Cited by 73
Self-citationLowary, T. L., & Hindsgaul, O. (1993) · Carbohydrate Research · doi:10.1016/0008-6215(93)84068-h · Cited by 64
Porcine A blood group-specific N-acetylgalactosaminyltransferase.
Schwyzer, M., & Hill, R. L. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40561-8 · Cited by 60
Substrate analogues to study cell-wall biosynthesis and its inhibition
Lazar, K. L., & Walker, S. (2002) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(02)00355-1 · Cited by 47
Enzymatic synthesis of blood group A and B trisaccharide analogues
Seto, N. O. L., Compston, C. A., Szpacenko, A., & Palcic, M. M. (2000) · Carbohydrate Research · doi:10.1016/s0008-6215(99)00297-9 · Cited by 47
Self-citationNguyen, H. P., Seto, N. O. L., Cai, Y., Leinala, E. K., Borisova, S. N., Palcic, M. M., & Evans, S. V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308770200 · Cited by 33
Self-citation
Cited by
Glycosyltransferases: Structures, Functions, and Mechanisms
Lairson, L. L., Henrissat, B., Davies, G. J., & Withers, S. G. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.76.061005.092322 · Cited by 2,079
Blood Groups in Infection and Host Susceptibility
Cooling, L. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00109-14 · Cited by 632
Structural Basis for the Recognition of Blood Group Trisaccharides by Norovirus
Cao, S., Lou, Z., Tan, M., Chen, Y., Liu, Y., Zhang, Z., Zhang, X. C., Jiang, X., Li, X., & Rao, Z. (2007) · Journal of Virology · doi:10.1128/jvi.00219-07 · Cited by 387
Glycosyltransferase structural biology and its role in the design of catalysts for glycosylation
Chang, A., Singh, S., Phillips, G. N., & Thorson, J. S. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.04.013 · Cited by 176
Glycosyltransferases and Glycan-Processing Enzymes
Rini, J. M., & Esko, J. D. (2009) · Europe PMC (PubMed Central) · doi:10.1101/glycobiology.3e.006 · Cited by 99
Metadata
- Authors
- Letts, J. A., Rose, N. L., Fang, Y. R., Barry, C. H., Borisova, S. N., Seto, N. O. L., Palcic, M. M., & Evans, S. V.
- Affiliations
- University of Victoria (CA)
- University of Alberta (CA)
- Corresponding author
- Evans, Stephen V.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 281
- Issue
- 6
- Pages
- 3625-3632
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2078159093
- Semantic Scholar
- 1491223742de1c191b4a29dca5301a266b3e2b16
- Cited by
- 51
- References
- 19
- Citations by year
- 2026: 2 · 2024: 2 · 2022: 1 · 2019: 2 · 2018: 2 · 2017: 2 · 2016: 3 · 2015: 3 · 2014: 3 · 2013: 9 · 2012: 5
- FWCI
- 0.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5353 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Michael Smith Health Research BC
- Alberta Glycomics Centre
- Canadian Institutes of Health Research
- Natural Sciences and Engineering Research Council of Canada
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Keywords
- ABO blood group system, crystal structure, critical amino acid residues, fucosyltransferase, enzyme inhibitors
- MeSH terms
- ABO Blood-Group System, Antigens, Binding Sites, Catalysis, Electrons, Galactosyltransferases, Gene Expression Regulation, Glycine, Glycolipids, Humans, Kinetics, Leucine, Models, Chemical, Models, Molecular, Monosaccharides, Oligosaccharides, Protein Binding, Proteins, Trisaccharides, Glycosyltransferases, Crystallography, X-Ray, Catalytic Domain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-17, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-17 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.